Literature DB >> 15509536

Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production.

Rebecca J Hodges1, R Gisli Jenkins, Caroline P D Wheeler-Jones, Danielle M Copeman, Stephen E Bottoms, Geoffrey J Bellingan, Carmel B Nanthakumar, Geoffrey J Laurent, Stephen L Hart, Martyn L Foster, Robin J McAnulty.   

Abstract

Levels of prostaglandin E(2) (PGE(2)), a potent inhibitor of fibroblast function, are decreased in the lungs of patients with pulmonary fibrosis, which has been shown to be because of limited expression of cyclooxygenase-2 (COX-2). To further investigate the relative importance of COX-2 and PGE(2) in the development of fibrosis we have used a selective COX-2 inhibitor and COX-2-deficient ((-/-) and (+/-)) mice in studies of bleomycin-induced lung fibrosis. We demonstrate in wild-type mice that bleomycin-induced lung PGE(2) production is predominantly COX-2 mediated. Furthermore, COX-2(+/-) mice show limited induction of PGE(2) and an enhanced fibrotic response with increased lung collagen content compared with wild-type mice after bleomycin injury (P < 0.001). In contrast, COX-2(-/-) mice show increased levels of lung PGE(2), compared with wild-type mice after injury (P < 0.05), because of compensatory up-regulation of COX-1, which appears to be associated with macrophage/monocytes but not fibroblasts derived from these mice. COX-2(-/-) mice show an enhanced and persistent inflammatory response to bleomycin, however the fibrotic response to injury was unaltered compared with wild-type animals. These data provide further direct evidence for the importance of up-regulating COX-2 and PGE(2) expression in protecting against the development of fibrosis after lung injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509536      PMCID: PMC1618657          DOI: 10.1016/S0002-9440(10)63423-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

Authors:  O Morteau; S G Morham; R Sellon; L A Dieleman; R Langenbach; O Smithies; R B Sartor
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis.

Authors:  James C Bonner; Annette B Rice; Jennifer L Ingram; Cindy R Moomaw; Abraham Nyska; Alyce Bradbury; Alisha R Sessoms; Patricia C Chulada; Daniel L Morgan; Darryl C Zeldin; Robert Langenbach
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

3.  The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts.

Authors:  R H Goldstein; P Polgar
Journal:  J Biol Chem       Date:  1982-08-10       Impact factor: 5.157

4.  Cyclooxygenase-2-deficient mice are resistant to endotoxin-induced inflammation and death.

Authors:  Kuniaki Ejima; Matthew D Layne; Irvith M Carvajal; Patricia A Kritek; Rebecca M Baron; Yen-Hsu Chen; Jeffrey Vom Saal; Bruce D Levy; Shaw-Fang Yet; Mark A Perrella
Journal:  FASEB J       Date:  2003-05-08       Impact factor: 5.191

5.  Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation.

Authors:  Jill E Kolodsick; Marc Peters-Golden; Jose Larios; Galen B Toews; Victor J Thannickal; Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05-08       Impact factor: 6.914

6.  Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent.

Authors:  Vibha Lama; Bethany B Moore; Paul Christensen; Galen B Toews; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2002-12       Impact factor: 6.914

7.  Modulation of collagen production by fibroblasts. Effects of chronic exposure to agonists that increase intracellular cyclic AMP.

Authors:  L E Saltzman; J Moss; R A Berg; B Hom; R G Crystal
Journal:  Biochem J       Date:  1982-04-15       Impact factor: 3.857

8.  Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis.

Authors:  Sylvain Marchand-Adam; Joëlle Marchal; Murielle Cohen; Paul Soler; Bénédicte Gerard; Yves Castier; Guy Lesèche; Dominique Valeyre; Hervé Mal; Michel Aubier; Monique Dehoux; Bruno Crestani
Journal:  Am J Respir Crit Care Med       Date:  2003-08-28       Impact factor: 21.405

9.  Effect of cyclic AMP on the intracellular degradation of newly synthesized collagen.

Authors:  B J Baum; J Moss; S D Breul; R A Berg; R G Crystal
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

10.  Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages.

Authors:  C A Rouzer; W A Scott; A L Hamill; Z A Cohn
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more
  54 in total

1.  Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-1.

Authors:  Steven K Huang; Scott H Wettlaufer; Jooho Chung; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-17       Impact factor: 6.914

2.  A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.

Authors:  Yasmina Bauer; John Tedrow; Simon de Bernard; Magdalena Birker-Robaczewska; Kevin F Gibson; Brenda Juan Guardela; Patrick Hess; Axel Klenk; Kathleen O Lindell; Sylvie Poirey; Bérengère Renault; Markus Rey; Edgar Weber; Oliver Nayler; Naftali Kaminski
Journal:  Am J Respir Cell Mol Biol       Date:  2015-02       Impact factor: 6.914

3.  SARS-CoV regulates immune function-related gene expression in human monocytic cells.

Authors:  Wanchung Hu; Yu-Ting Yen; Sher Singh; Chuan-Liang Kao; Betty A Wu-Hsieh
Journal:  Viral Immunol       Date:  2012-08       Impact factor: 2.257

4.  Diallyl disulfide inhibits proliferation and transdifferentiation of lung fibroblasts through induction of cyclooxygenase and synthesis of prostaglandin E₂.

Authors:  Yanhua Wang; Rong Cao; Bo Wei; Xiaoyu Chai; Dan Sun; Y Guan; Xin-min Liu
Journal:  Mol Cell Biochem       Date:  2014-04-23       Impact factor: 3.396

5.  Prostaglandin E₂ and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function.

Authors:  Angela C Baird; Frances Lloyd; Ian C Lawrance
Journal:  Dig Dis Sci       Date:  2015-01-29       Impact factor: 3.199

6.  Suppression of von Hippel-Lindau Protein in Fibroblasts Protects against Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Qiyuan Zhou; Tianji Chen; Wei Zhang; Melike Bozkanat; Yongchao Li; Lei Xiao; Richard B van Breemen; John W Christman; Jacob I Sznajder; Guofei Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2016-05       Impact factor: 6.914

7.  A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.

Authors:  Yuanjue Zhu; Yong Liu; Weixun Zhou; Ruolan Xiang; Lei Jiang; Kewu Huang; Yu Xiao; Zijian Guo; Jinming Gao
Journal:  Respir Res       Date:  2010-03-20

8.  Tgf-Beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma.

Authors:  Stephen E Bottoms; Jane E Howell; Alistair K Reinhardt; Iona C Evans; Robin J McAnulty
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

9.  Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.

Authors:  James C Bonner
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-25

10.  Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression.

Authors:  Fei Liu; Justin D Mih; Barry S Shea; Alvin T Kho; Asma S Sharif; Andrew M Tager; Daniel J Tschumperlin
Journal:  J Cell Biol       Date:  2010-08-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.